CTI BioPharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is July - June.

Millions EUR. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jul '25 Jul 31, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2015 - 2019
Market Capitalization	4	39	66	-	-	-	Upgrade
Market Cap Growth	-40.93%	-40.93%	-	-	-	-	Upgrade
Enterprise Value	44	83	105	-	-	-	Upgrade
Last Close Price	0.45	4.76	8.05	-	-	-	Upgrade
PE Ratio	-	-	118.14	-	-	-	Upgrade
PS Ratio	0.06	0.59	1.25	-	-	-	Upgrade
PB Ratio	0.11	1.18	2.01	-	-	-	Upgrade
P/TBV Ratio	4.22	44.72	233.78	-	-	-	Upgrade
P/OCF Ratio	0.64	6.76	11.37	-	-	-	Upgrade
EV/Sales Ratio	0.66	1.24	1.96	-	-	-	Upgrade
EV/EBITDA Ratio	5.05	14.65	28.62	-	-	-	Upgrade
EV/EBIT Ratio	19.62	36.95	-	-	-	-	Upgrade
Debt / Equity Ratio	1.37	1.37	1.24	2.46	2.76	3.44	Upgrade
Debt / EBITDA Ratio	5.18	5.18	11.25	5.06	5.53	8.00	Upgrade
Asset Turnover	0.69	0.69	0.62	0.91	1.01	-	Upgrade
Inventory Turnover	3.16	3.16	2.23	2.45	3.02	-	Upgrade
Quick Ratio	0.41	0.41	0.28	0.84	0.93	0.86	Upgrade
Current Ratio	0.75	0.75	0.72	1.38	1.47	1.17	Upgrade
Return on Equity (ROE)	1.12%	1.12%	2.40%	20.12%	24.60%	-	Upgrade
Return on Assets (ROA)	1.44%	1.44%	-0.73%	3.57%	1.93%	-	Upgrade
Return on Capital (ROIC)	1.84%	1.84%	-0.95%	4.85%	2.70%	-	Upgrade
Return on Capital Employed (ROCE)	3.70%	3.70%	-	8.90%	5.10%	-	Upgrade
Earnings Yield	-0.70%	-0.07%	0.85%	-	-	-	Upgrade
FCF Yield	-101.41%	-9.56%	-10.75%	-	-	-	Upgrade
Payout Ratio	-	-	106.76%	21.25%	23.67%	114.89%	Upgrade
Buyback Yield / Dilution	-2.55%	-2.55%	-40.11%	-	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.